DrugRisk Update: U.K. Health Agency Warns of Blood Clots from Yaz

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz settlement
The resource center has also added info showing Bayer has spent nearly $1.575 billion so far to settle around 7,660 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT).

New York, NY (PRWEB) February 19, 2014

The birth control safety advocates at DrugRisk.com are announcing new information to the site for patients who’ve taken the drugs Yaz or Yasmin. Britain’s healthcare agency recently ordered doctors to inform women taking drugs like Yaz and Yasmin that they were twice as likely to develop blood clots*.

The news comes as court records show thousands of cases still pending in the U.S. alleging the drugs caused blood clot injuries**.

DrugRisk is a free resource offering the latest news, safety alerts, product recalls and litigation updates to those taking popular prescription drugs. Visitors can find out if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.

The resource center has added health warnings from experts including the British Medical Journal*** and FDA**** that birth control pills like Yaz and Yasmin containing the hormone drospirenone can increase the risk of blood clots.

Now, DrugRisk has learned that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has ordered general practitioners to warn patients taking certain birth control pills, including Yasmin, that they are nearly twice as likely to develop blood clots*.

Due to the number of patients who have filed a Yaz lawsuit alleging side effects in the U.S., cases have been consolidated to a special federal court (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)). The latest court records show 9,781 claims pending**.

The resource center has also added info showing Bayer has spent nearly $1.575 billion so far to settle around 7,660 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)*****.

Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin, or with questions about the ongoing settlements, is urged to visit DrugRisk or speak with a lawyer about their legal options.

Due to the specialized nature of federal drug injury litigation, DrugRisk only recommends lawyers who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*British Journal of Family Medicine, Feb 2014; bjfm.co.uk/content/article.aspx?id=25769806997
**JPML 1/15/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-January-15-2014.pdf
***BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
****FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
*****Bayer Stockholder’s Newsletter, Explanatory Notes; Legal Risks, 10/31/13; stockholders-newsletter-q3-2013.bayer.com/en/explanatory-notes.aspx


Contact